Literature DB >> 3929086

The energy production of the adult Schistosoma mansoni is for a large part aerobic.

B E van Oordt, J M van den Heuvel, A G Tielens, S G van den Bergh.   

Abstract

Pairs of adult Schistosoma mansoni were collected by perfusion of the mesenteric veins of experimentally infected hamsters which were anaesthetized with ether. The parasites were incubated in a simple salt medium with D-[6-14C]glucose for 3 h at 37 degrees C. Under aerobic conditions a considerable amount of labelled CO2 was formed, indicating that the Krebs cycle was operative. Under anaerobic conditions or in the presence of cyanide no 14CO2 production occurred. Evidence that the aerobic 14CO2 production is linked with oxidative phosphorylation was derived from the observation that it was for the larger part inhibited by oligomycin, an inhibition which was completely released by the uncoupling agent FCCP. It can be calculated that under aerobic conditions at least one third of the energy production of adult schistosomes occurs in aerobic processes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929086     DOI: 10.1016/0166-6851(85)90080-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Molecular characterisation of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone.

Authors:  M R Fantappié; A Galina; R Luís de Mendonça; D R Furtado; W E Secor; D G Colley; R Corrêa-Oliveira; G Freeman; A J Tempone; L Lannes de Camargo; D F Rumjanek
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  The energy metabolism of Schistosoma mansoni during its development in the hamster.

Authors:  B E van Oordt; A G Tielens; S G van den Bergh
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

Review 3.  The metabolic control of schistosome egg production.

Authors:  Edward J Pearce; Stanley Ching-Cheng Huang
Journal:  Cell Microbiol       Date:  2015-04-30       Impact factor: 3.715

4.  Comparative metabolic profiling by 1H-NMR spectroscopy analysis reveals the adaptation of S. mansoni from its host to in vitro culture conditions: a pilot study with ex vivo and GSH-supplemented medium-cultured parasites.

Authors:  Valentina Fustaino; Roberto Gimmelli; Alessandra Guidi; Sara Lentini; Fulvio Saccoccia; Greta Petrella; Daniel Oscar Cicero; Giovina Ruberti
Journal:  Parasitol Res       Date:  2022-01-13       Impact factor: 2.289

5.  Towards an understanding of the mechanism of action of praziquantel.

Authors:  Anthony D Aragon; Reza A Imani; Vint R Blackburn; Pauline M Cupit; Sandra D Melman; Tinopiwa Goronga; Thomas Webb; Eric S Loker; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2008-11-28       Impact factor: 1.759

6.  Chlorpromazine, other amphiphilic cationic drugs and praziquantel: effects on carbohydrate metabolism of Schistosoma mansoni.

Authors:  A Harder; P Andrews; H Thomas
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  Praziquantel impairs the ability of exogenous serotonin to stimulate carbohydrate metabolism in intact Schistosoma mansoni.

Authors:  A Harder; J Abbink; P Andrews; H Thomas
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 8.  Human schistosomiasis.

Authors:  Daniel G Colley; Amaya L Bustinduy; W Evan Secor; Charles H King
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

9.  The Up-Regulation of Ribosomal Proteins Further Regulates Protein Expression Profile in Female Schistosoma japonicum after Pairing.

Authors:  Jun Sun; Chen Li; Suwen Wang
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

10.  Fatty acid oxidation is essential for egg production by the parasitic flatworm Schistosoma mansoni.

Authors:  Stanley Ching-Cheng Huang; Tori C Freitas; Eyal Amiel; Bart Everts; Erika L Pearce; James B Lok; Edward J Pearce
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.